H.A.M. van Diemen

The effect of 4‐aminopyridine on clinical signs in multiple sclerosis: A randomized, placebo‐controlled, double‐blind, cross‐over study

H.A.M. van Diemen, Chris H. Polman, Theo M. M. M. van Dongen et al. · Annals of Neurology · 1992 · 125 citations

Disability Status Scale, Neurological Disorder, Medicine +12

4-Aminopyridine in Patients with Multiple Sclerosis

H.A.M. van Diemen, Chris H. Polman, J.C. Koetsier et al. · Clinical Neuropharmacology · 1993 · 75 citations

4-Aminopyridine Is Superior to 3,4-Diaminopyridine in the Treatment of Patients With Multiple Sclerosis

Chris H. Polman, F.W. Bertelsmann, Reneé de Waal et al. · Archives of Neurology · 1994 · 58 citations

4-Aminopyridine induces functional improvement in multiple sclerosis patients: A neurophysiological study

H.A.M. van Diemen, Chris H. Polman, M.M.M.M. van Dongen et al. · Journal of the Neurological Sciences · 1993 · 55 citations

Multiple Sclerosis Patients, Neurobiology Of Disease, Neurological Disorder +9

A Pilot Study on the Influence of a Corticotropin (4-9) Analogue on Vinca Alkaloid--Induced Neuropathy

B. van Kooten, H.A.M. van Diemen, K. M. Groenhout et al. · Archives of Neurology · 1992 · 47 citations

Neuropathic Pain, Pharmacotherapy, Social Sciences +16